Blueprint Medicines Corporation

NasdaqGS:BPMC Stock Report

Market Cap: US$5.3b

Blueprint Medicines Corporation Company Information

Blueprint Medicines Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Blueprint Medicines Corporation
  • Ticker: BPMC
  • Exchange: NasdaqGS
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$5.271b
  • Shares Outstanding: 61.23m
  • Website: https://www.blueprintmedicines.com

Number of Employees


Location

  • Blueprint Medicines Corporation
  • 45 Sidney Street
  • Cambridge
  • Massachusetts
  • 2139
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BPMCNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDApr 2015
2L9DB (Deutsche Boerse AG)YesCommon StockDEEURApr 2015
0HOJLSE (London Stock Exchange)YesCommon StockGBUSDApr 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/04/17 00:00
End of Day Share Price 2024/04/17 00:00
Earnings2023/12/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.